William Haseltine, PhD, is chair and president of the think tank and advisory group ACCESS Health International, a former Harvard Medical School and School of Public Health professor and founder of the university’s cancer and HIV/AIDS research departments. 

In Dr. Haseltine’s career at the forefront of medical research and application, he has educated a generation of doctors at Harvard Medical School, designed the strategy to develop the first treatment for HIV/AIDS, is well known for his groundbreaking work on cancer, and led the team that pioneered the development of new drugs based on information from the human genome.  

He is also the founder of more than a dozen biotechnology companies including Human Genome Sciences. Eight pharmaceutical products from companies he founded are currently approved by U.S. and international regulatory agencies. He is internationally recognized as an expert on Covid-19 and has been published on the topic in CNN, Washington Post, Forbes, and Scientific American. You can keep up to date with his latest work at: https://www.williamhaseltine.com/

© 2024 BioFutureTM. All Rights Reserved

Produced by